First Horizon Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

First Horizon Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$497	Sell	6 -344	-98%	-$27.4K	﹤0.01%	2255
2025 Q1	$28.4K	Hold	350	–	–	﹤0.01%	1176
2024 Q4	$31.5K	Hold	350	–	–	﹤0.01%	1155
2024 Q3	$34.6K	Hold	350	–	–	﹤0.01%	1154
2024 Q2	$32.4K	Hold	350	–	–	﹤0.01%	1107
2024 Q1	$33.2K	Sell	350 -471	-57%	-$43.7K	﹤0.01%	1143
2023 Q4	$73.3K	Buy	821 +250	+44%	+$18.6K	﹤0.01%	764
2023 Q3	$41.7K	Hold	571	–	–	﹤0.01%	924
2023 Q2	$47.5K	Hold	571	–	–	﹤0.01%	907
2023 Q1	$43.5K	Buy	571 +221	+63%	+$18.3K	﹤0.01%	938
2022 Q4	$29.1K	Hold	350	–	–	﹤0.01%	1112
2022 Q3	$28K	Hold	350	–	–	﹤0.01%	1091
2022 Q2	$26K	Sell	350 -9	-3%	-$676	﹤0.01%	1196
2022 Q1	$32K	Hold	359	–	–	﹤0.01%	766
2021 Q4	$40K	Hold	359	–	–	﹤0.01%	1018
2021 Q3	$45K	Buy	359 +350	+3,889%	+$45.1K	﹤0.01%	952
2021 Q2	$1K	Hold	9	–	–	﹤0.01%	1916
2021 Q1	$1K	Hold	9	–	–	﹤0.01%	1827
2020 Q4	$1K	Buy	+9	New	+$1.15K	﹤0.01%	1423
2014 Q2	–	Sell	-1,200	Closed	-$57K	–	1578
2014 Q1	$57K	Hold	1,200	–	–	0.01%	483
2013 Q4	$52K	Hold	1,200	–	–	0.01%	478
2013 Q3	$52K	Buy	+1,200	New	+$48.6K	0.01%	445

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

First Horizon Advisors's XBI Position: Q2 2025 in Review

First Horizon Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 98% in Q2 2025, selling an estimated $27.4K and leaving 6 shares worth $497. The position accounts for ﹤0.01% of the portfolio, ranked #2255.

First Horizon Advisors first reported a position in XBI in Q3 2013 and has held it in 22 quarters since. The position peaked at $73.3K in Q4 2023. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

First Horizon Advisors held 6 shares of State Street SPDR S&P Biotech ETF worth $497 as of Q2 2025.
First Horizon Advisors sold 344 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $27.4K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #2255 holding.
First Horizon Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2013 and has held it in 22 quarters since.
First Horizon Advisors's State Street SPDR S&P Biotech ETF position peaked at $73.3K in Q4 2023.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.